Every shortcut you take in research comes back—twice as costly.

I learned this the hard way….

Three years back, while waiting for some data, I thought, “Why not knock out a quick systematic review?”

Weeks turned into months… and eventually almost a year.

The faster you chase publications, the slower they seem to arrive.

The slow way is the fast way—because the fast way never gets you there.

In research, rushing feels like progress but often ends in stagnation.

I’ve seen it first-hand:

• Half-baked studies
• Rejected manuscripts
• Burned-out teams

It looks like productivity, but it feels like drowning.

Rushing creates short-term thinking, which creates long-term problems.

When you rush:

• You design studies around the dataset you have, not the question that matters.
• You cut corners on rigor, hoping reviewers won’t notice.
• You chase “trendy” topics that fade before your paper even gets published.

The math is simple: every shortcut you take today creates 2 new problems tomorrow.

The deeper truth

→ You need a cohesive research program anchored in your mission and vision.

→ Every project should tie back to that.

→ Everything that doesn’t? It’s a NO.

That means turning down plenty of “great opportunities”—especially the quick ones.

Because scattered wins don’t compound. Cohesive ones do.

The real race isn’t about being first.

It’s about still being credible and still being aligned, when others have burned out.

If you keep showing up with rigor, clarity, and patience, you won’t just be standing. You’ll be leading.

Here are 5 Strategies (I’ve found helpful) to Practice Long-Term Thinking in Research 👇

1) Define your mission + vision clearly

Write one sentence for your mission (your field + population + outcome) and one for your vision (how your work changes practice in 5–10 years).

Use them as a filter for everything—datasets, collaborations, journals, talks, grants. Before you say yes, ask: Does this serve my mission? If not, it’s a polite pass.

• Keep these statements visible where you work.
• Let them guide your weekly priorities and which invitations you decline.

🔍 Example: You’re focused on cardiovascular outcomes in heart failure. A colleague offers a dermatology case series. Tempting for an extra line on the CV, but it doesn’t move your program forward. You say “No” and invest that time in refining an SGLT2 inhibitor proposal for HFpEF.

2) Validate your study design upfront

Slow down before you touch data.

Map the Problem–Gap–Hook so you know what’s known, what’s unknown, and why it matters now.

Draft a mini analysis plan: population, exposures, outcomes, covariates, modeling approach, sensitivity analyses.

Book a short consult with a biostatistician to confirm power and feasibility. A 45-minute conversation can save six months of rework.

• Treat underpowered or misaligned designs as avoidable preventable errors.
• Don’t collect data you can’t analyze credibly; don’t analyze data that can’t answer the question.

🔍 Example: Instead of a quick chart review of 50 patients with diabetes, you power a study to detect a 0.5% HbA1c difference with appropriate variance and adjustment. Start is delayed two weeks, but you avoid an underpowered, unpublishable study.

3) Choose your collaborators wisely

Work with people who share your long-term vision and complement your skills.

Reliability beats flash; process fit beats prestige.

Clarify roles, timelines, analysis ownership, and authorship early (one page is enough).

Protect your bandwidth: 1 strong co-lead > 3 inconsistent helpers.

• Favor collaborators who ship on time and respect your time.
• Build a repeat crew who can execute across multiple aligned projects.

🔍 Example: You decline a spot as author #25 on a large genetics consortium that doesn’t align with your agenda. Instead, you deepen collaboration with a local epidemiologist who co-leads a series of aligned studies on risk prediction in inflammatory arthritis.

4) Choose questions that last

Ask: “Will this still matter in five years?”

Refine until the answer is yes.

Favor patient-centered, guideline-informing endpoints and questions that remain relevant beyond a news cycle or fleeting method trends.

Use trends only when they clarify your core program.

• Anchor to clinical decisions, care pathways, and outcomes patients feel.
• Let short-term data serve long-term questions—not the other way around.

🔍 Example: During the pandemic, rather than chasing every COVID-19 dataset, you study viral infections as triggers for autoimmune flares and their impact on long-term treatment response—a durable, mission-aligned question.

5) Invest in systems, not speed

Build once, reuse forever.

Create shared templates for IRB language, STROBE/CONSORT/PRISMA checklists, boilerplate methods, and journal styles.

Standardize data pipelines in R or Stata (cleaning, variable dictionaries, QC checks).

Use a reference manager with shared libraries.

Apply minimalist AI to repeatable tasks—structuring sections, spotting inconsistencies against your tables, generating reviewer-style checklists—while keeping judgment human.

• Systems reduce error, accelerate onboarding, and free time for thinking.
• Your future self (and your team) will thank you.

🔍 Example: You spend a week writing a reproducible R script for EHR cleaning in hypertension. The next three studies start clean, run faster, and pass internal QC without drama.

When your mission filters decisions – Your designs are powered and principled. Your collaborators are deliberate. Your questions endure. Your systems hum. And your work begins to compound on its own.

That’s the paradox: the moment you stop sprinting for quick wins, momentum finds you.

Keep the bar high, keep the focus tight, and let time do what it does best—turn rigor into reputation and reputation into real-world impact.

The slow way isn’t just the fast way; it’s the way you lead.

What’s one “quick win” you’ve said no to recently because it didn’t fit your long-term mission?

PROMPT OF THE WEEK:

Speaking of creating systems, creating AI prompts and custom GPTs for a specific research use case can give you significant leverage.

Important – avoid any patient identifiers and verify all AI output (AI can’t take responsibility, you have to).

Data analysis

(P) Personal (Persona)
You are a senior biostatistician and data analyst for clinical/EHR datasets. You are meticulous, transparent, and reproducible. Explain methods briefly, then show results with clear numbers/units. Validate all reported figures against the provided data; if something can’t be computed, state “Not available” and list what’s missing.

(G) Goal
Analyze the dataset to produce a structured, decision-ready report that covers:
1) Key insights: significant trends, distributions, correlations (Pearson/Spearman as appropriate), outliers, and summary stats (mean, median, SD/IQR).
2) Comparative analysis: stratified comparisons by specified groups (e.g., time, treatment, category, demographics) with appropriate tests/effect sizes and 95% CIs.
3) Predictive insights: identify potential predictive patterns/relationships; if feasible, outline a simple baseline model (features, target, metrics you’d use such as AUC/RMSE) without overfitting claims.
4) Data quality: missingness patterns (per variable), inconsistencies, duplicates, implausible values, and potential sources of bias (selection, measurement, confounding).
5) Visualization recommendations: the 5–7 most effective plots (what + why), mapping each to the insight it would communicate.
6) Actionable recommendations: concrete next steps for analysis, data cleaning, and stakeholder decisions.

(O) Output Format
Return a Markdown report with these sections:
- Executive Summary (≤150 words)
- Dataset Snapshot (n, variables, time range, key fields)
- 1) Key Insights (bullets + a small summary table of key stats)
- 2) Comparative Analysis (brief methods + a compact comparison table)
- 3) Predictive Insights (candidate signals + model outline and success metrics)
- 4) Data Quality (table of missingness %, flagged issues, bias notes)
- 5) Visualization Plan (table: Plot | Purpose | Fields | Rationale)
- 6) Actionable Next Steps (numbered list)
- Assumptions & Limitations (bullets)

(A) Avoid
- Do not fabricate results, impute values, or imply causality from observational patterns.
- Do not report PHI or sensitive identifiers.
- Don’t over-interpret small subgroup results; flag them instead.
- If inputs are insufficient, don’t proceed—return a concise “Inputs needed” checklist.

(L) Lens of Context
Project context: [insert 1–2 sentences on study/business question and why this analysis matters].
Dataset: [name/link or attachment]; schema summary (key columns, units, time window, population, inclusion/exclusion).
Primary questions: [list 2–4].
Strata for comparisons: [e.g., treatment arm, sex, age bands, site, time period].
Outcome(s)/targets (if any): [define clearly + units].
Constraints: [privacy/policy limits, compute limits].
Audience: [e.g., clinical PI + ops stakeholders—prefer concise, decision-oriented language].

P.S. Tomorrow is the day → I am running a launch event webinar where I will be teaching ” How to Leverage AI for Clinical Research (with Research Boost)” tomorrow 9/06/2025, 10 to 11 am CST (11am to 12 pm CST).

Hope to see you there.

Your last chance to sign up here FREE (spots are limited): https://risingresearcheracademy.com/aitraining/